Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Patent
1995-01-20
1998-12-08
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
424 9371, 435325, C12N 500
Patent
active
058465294
ABSTRACT:
The invention provides a method of treating a patient having a reduced population of neutrophils following a myeloablative cancer treatment such as high dose chemotherapy. Following myeloablative therapy, a cell composition of at least 25% neutrophil precursors, i.e. promyelocytes, myelocytes, and metamyelocytes, is administered to the patient. Thereafter, the neutrophil precursors differentiate rapidly in vivo to replenish the supply of mature neutrophils for fighting infection. The method is used to reduce the neutropenic window between the time of myeloablative therapy and the time required for infused stem cells to proliferate and differentiate into mature neutrophils.
REFERENCES:
patent: 4786599 (1988-11-01), Chessebeuf et al.
patent: 4816401 (1989-03-01), Taupier et al.
patent: 5004681 (1991-04-01), Boyse et al.
patent: 5045467 (1991-09-01), Bertheussen
patent: 5063157 (1991-11-01), Stockinger
patent: 5135866 (1992-08-01), Herfetz et al.
patent: 5155036 (1992-10-01), Hagiwara et al.
patent: 5199942 (1993-04-01), Gillis
patent: 5232848 (1993-08-01), Wolfe et al.
patent: 5541103 (1996-07-01), Kanz et al.
ATCC "Hybridomas" in: Catalogue of Cell Lines & Hybridomas, 7th ed., pp. 320, 348, 374, 421 (1992).
ATCC Catalogue of Cell Lines and Hybridomas, 6th ed., pp. 342-355 (1988).
Bjare, Pharma. Ther. 53:355-374 (1992).
Bruno et al., "Effect of Interleukin 6 and Interleukin 1 on in vitro Human Megakaryocytopoiesis: Its Interaction with Other Cytokines," Exp. Hematol. 17:1038-1043 (1989).
Burrow et al., Proc. Natl. Acad. Sci. 90:6066-6070 (1993).
Da et al., Brit. J. Haematol. 78:42-47 (1991).
Dexter et al., J Cell Physiol 91:335 (1977).
Douay et al., Exp. Hematol. 14:358-365 (1986).
Drouet et al., J. of Haemotol. 73 (2):143-147 (1989).
Egeland et al.,"Myeloid Differentiation of Purified CD34.sup.+ Cells After Stimulation With Recombinant Human Granulocyte-Monocyte Colony-Stimulating Factor (CSF), Granulocyte-CSF, Monocyte-CSF, and Interleukin-3", Blood, 78 (12):3192-3199 (1991).
Hardwick et al., J. Hematother. 1:379-386 (1992).
Hayrock, Blood 80 (6), pp. 1406-1412 (1992).
Jakoby et al. (eds.), Meth. in Enzymology LVIII (Cell Culture): 44-109 (1979).
Jandl, Blood, Textbook of Hematology 441-480 (1987).
Koike et al., "Interleukin-6 Enhances Murine Megakaryocytopoiesis in Serum-Free Culture," Blood 75 (12):2286-2291 (1990).
Koller et al., Bio/Tech. 11:358-363.
Kubota et al., "Murine Granulocyte/Macrophage and Megacaryocyte Colony Formation in Serum-Free Cultures," Biol. Abs. 82 (1986).
Lansdorp et al., J. Exp. Med. 175:1501-1509 (1991).
Long, Stem Cells 11:33-44 (1993).
Marmont et al., Atlas of Blood Cells, Function and Pathology in "Neutrophils" pp. 159-190.
Merchav et al., Intl. J. Cell Cloning 2:356-367 (1984).
Metcalf et al., Proc. Natl. Acad. Sci. 72:1744 (1975).
Nakef et al., Ser Heamat 8:4 (1975).
Okano et al. ACTA Haemotol. (JPN) 53:1213-1221 (1990).
Paulus, "Platelet kinetics" in: Williams et al. (eds.) Hematol. 1251-1260 (1990).
Ponting et al., Growth Factors 4:165-713 (1991).
Smith et al., Exp. Hematol. 21:870-877 (1993).
Somerville et al., "Future Directions in Transplantation: Xenotransplantation," Kidney Intl. 44 (suppl 42): S-112-S-121 (1993).
Spitzer et al., Blood 55:317-323.
Spooncer et al., Differentiation 31:111-118 (1986).
Teramura et al., "Clonal Growth of Human Megakaryocyte Progenitors in Serum-Free Cultures: Effect of Recombinant Human Interleukin 3" Exp. Hematol. 16:843-848 (1988).
Vincent et al., Exp. Hematol. 20 (1):17-23 (1992).
Warren et al., "The Role of Interleukin 6 and Interleukin 1 in Megakaryocyte Development," Exp. Hematol. 17 (11), pp. 1095-1099 (1989).
Wu et al., Pathol. 22:145-148 (1990).
Bender James G.
Loudovaris Maureen F.
Maciukas Susan M.
Qiao Xiaoying
Smith Stephen L.
Lankford , Jr. Leon B.
Nexell Therapeutics Inc.
LandOfFree
Infusion of neutrophil precursors for treatment of neutropenia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Infusion of neutrophil precursors for treatment of neutropenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Infusion of neutrophil precursors for treatment of neutropenia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174495